Cryo-Cell International, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Stock Option Activity for Options (Detail)

Stockholders' Equity - Stock Option Activity for Options (Detail) (USD $)	12 Months Ended
	Nov. 30, 2014	Nov. 30, 2013
Performance and Market-Based Vesting Condition Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at November 30, 2013, Options	640,000
Granted, Options	0
Exercised, Options	0
Expired/forfeited, Options	(640,000)
Outstanding at November 30, 2013, Options	0	640,000
Exercisable at November 30, 2014, Options	0
Outstanding at November 30, 2012, Weighted Average Exercise Price	$ 1.74
Granted, Weighted Average Exercise Price	$ 0
Exercised, Weighted Average Exercise Price	$ 0
Expired/forfeited, Weighted Average Exercise Price	$ 1.74
Outstanding at November 30, 2014, Weighted Average Exercise Price	$ 0	$ 1.74
Exercisable at November 30, 2014, Weighted Average Exercise Price	$ 0
Outstanding at November 30, 2013, Weighted Average Remaining Contractual Life (Years		7 years 9 months 29 days
Outstanding at November 30, 2013, Aggregate Intrinsic Value	$ 70,000
Outstanding at November 30, 2014, Aggregate Intrinsic Value		70,000
Exercisable at November 30, 2014, Aggregate Intrinsic Value
Service-Based Vesting Condition Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at November 30, 2013, Options	1,112,260
Granted, Options	22,500
Exercised, Options	(51,245)
Expired/forfeited, Options	(86,249)
Outstanding at November 30, 2013, Options	997,266	1,112,260
Exercisable at November 30, 2014, Options	970,183
Outstanding at November 30, 2012, Weighted Average Exercise Price	$ 2.11
Granted, Weighted Average Exercise Price	$ 2.40
Exercised, Weighted Average Exercise Price	$ 1.54
Expired/forfeited, Weighted Average Exercise Price	$ 2.15
Outstanding at November 30, 2014, Weighted Average Exercise Price	$ 2.14	$ 2.11
Exercisable at November 30, 2014, Weighted Average Exercise Price	$ 2.14
Outstanding at November 30, 2013, Weighted Average Remaining Contractual Life (Years	5 years 10 months 2 days	6 years 4 months 24 days
Exercisable at November 30, 2014, Weighted Average Remaining Contractual Life (Years	5 years 10 months 2 days
Outstanding at November 30, 2013, Aggregate Intrinsic Value	88,614
Granted, Aggregate Intrinsic Value	8,550
Exercised, Aggregate Intrinsic Value	56,077
Expired/forfeited, Aggregate Intrinsic Value	54,454
Outstanding at November 30, 2014, Aggregate Intrinsic Value	661,466	88,614
Exercisable at November 30, 2014, Aggregate Intrinsic Value	$ 649,134